Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 13, 2024 Filed Feb 15, 2024 19:52 UTC |
Cano Health, Inc.10% owner
|
SaleClass A Common Stock | 56,330 | $0.76 | $42,810.80 |
DisclosureSEC source: 0001209191-24-003420 · doc4.xml · nonDerivative · entry 1 Cano Health, Inc. · CIK 0001800682 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 5,212,632 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.75 to $0.7877. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer. Read SEC document |
| February 12, 2024 Filed Feb 12, 2024 18:44 UTC |
Cano Health, Inc.10% owner
|
SaleClass A Common Stock | 22,767 | $0.77 | $17,530.59 |
DisclosureSEC source: 0001209191-24-003126 · doc4.xml · nonDerivative · entry 3 Cano Health, Inc. · CIK 0001800682 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 5,268,962 F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.76 to $0.81. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer. Read SEC document |
| February 09, 2024 Filed Feb 12, 2024 18:44 UTC |
Cano Health, Inc.10% owner
|
SaleClass A Common Stock | 59,737 | $0.79 | $47,192.23 |
DisclosureSEC source: 0001209191-24-003126 · doc4.xml · nonDerivative · entry 2 Cano Health, Inc. · CIK 0001800682 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 5,291,729 F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.77 to $0.8095. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 18:44 UTC |
Cano Health, Inc.10% owner
|
SaleClass A Common Stock | 42,419 | $0.78 | $33,086.82 |
DisclosureSEC source: 0001209191-24-003126 · doc4.xml · nonDerivative · entry 1 Cano Health, Inc. · CIK 0001800682 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 5,351,466 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.76 to $0.81. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer. Read SEC document |
| February 07, 2024 Filed Feb 7, 2024 19:00 UTC |
Cano Health, Inc.10% owner
|
SaleClass A Common Stock | 80,757 | $0.76 | $61,375.32 |
DisclosureSEC source: 0001209191-24-002969 · doc4.xml · nonDerivative · entry 3 Cano Health, Inc. · CIK 0001800682 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 5,393,885 F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.73 to $0.82. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer. Read SEC document |
| February 06, 2024 Filed Feb 7, 2024 19:00 UTC |
Cano Health, Inc.10% owner
|
SaleClass A Common Stock | 65,945 | $0.82 | $54,074.90 |
DisclosureSEC source: 0001209191-24-002969 · doc4.xml · nonDerivative · entry 2 Cano Health, Inc. · CIK 0001800682 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 5,474,642 F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.8016 to $0.925. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 19:00 UTC |
Cano Health, Inc.10% owner
|
SaleClass A Common Stock | 53,355 | $0.92 | $49,086.60 |
DisclosureSEC source: 0001209191-24-002969 · doc4.xml · nonDerivative · entry 1 Cano Health, Inc. · CIK 0001800682 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 5,540,587 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.88 to $0.9832. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer. Read SEC document |
| February 02, 2024 Filed Feb 2, 2024 20:22 UTC |
Cano Health, Inc.10% owner
|
SaleClass A Common Stock | 41,219 | $1.07 | $44,104.33 |
DisclosureSEC source: 0001209191-24-002735 · doc4.xml · nonDerivative · entry 3 Cano Health, Inc. · CIK 0001800682 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 5,593,942 F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.06 to $1.10. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 20:22 UTC |
Cano Health, Inc.10% owner
|
SaleClass A Common Stock | 71,190 | $1.08 | $76,885.20 |
DisclosureSEC source: 0001209191-24-002735 · doc4.xml · nonDerivative · entry 2 Cano Health, Inc. · CIK 0001800682 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 5,635,161 F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.06 to $1.10. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:22 UTC |
Cano Health, Inc.10% owner
|
SaleClass A Common Stock | 53,279 | $1.10 | $58,606.90 |
DisclosureSEC source: 0001209191-24-002735 · doc4.xml · nonDerivative · entry 1 Cano Health, Inc. · CIK 0001800682 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 5,706,351 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.08 to $1.125. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer. Read SEC document |
| January 30, 2024 Filed Jan 31, 2024 17:06 UTC |
Cano Health, Inc.10% owner
|
SaleClass A Common Stock | 93,277 | $1.12 | $104,470.24 |
DisclosureSEC source: 0001209191-24-002503 · doc4.xml · nonDerivative · entry 2 Cano Health, Inc. · CIK 0001800682 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 5,759,630 F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.11 to $1.155. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 17:06 UTC |
Cano Health, Inc.10% owner
|
SaleClass A Common Stock | 43,972 | $1.21 | $53,206.12 |
DisclosureSEC source: 0001209191-24-002503 · doc4.xml · nonDerivative · entry 1 Cano Health, Inc. · CIK 0001800682 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 5,852,907 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.20 to $1.23. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer. Read SEC document |
| January 26, 2024 Filed Jan 26, 2024 17:40 UTC |
Cano Health, Inc.10% owner
|
SaleClass A Common Stock | 121,689 | $1.19 | $144,809.91 |
DisclosureSEC source: 0001209191-24-002306 · doc4.xml · nonDerivative · entry 3 Cano Health, Inc. · CIK 0001800682 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 5,896,879 F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.17 to $1.23. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer. Read SEC document |
| January 25, 2024 Filed Jan 26, 2024 17:40 UTC |
Cano Health, Inc.10% owner
|
SaleClass A Common Stock | 35,165 | $1.18 | $41,494.70 |
DisclosureSEC source: 0001209191-24-002306 · doc4.xml · nonDerivative · entry 2 Cano Health, Inc. · CIK 0001800682 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 6,018,568 F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.18 to $1.22. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer. Read SEC document |
| January 24, 2024 Filed Jan 26, 2024 17:40 UTC |
Cano Health, Inc.10% owner
|
SaleClass A Common Stock | 72,265 | $1.20 | $86,718.00 |
DisclosureSEC source: 0001209191-24-002306 · doc4.xml · nonDerivative · entry 1 Cano Health, Inc. · CIK 0001800682 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 6,053,733 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.18 to $1.23. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer. Read SEC document |
| January 23, 2024 Filed Jan 24, 2024 17:06 UTC |
Cano Health, Inc.10% owner
|
SaleClass A Common Stock | 470,882 | $1.26 | $593,311.32 |
DisclosureSEC source: 0001209191-24-002183 · doc4.xml · nonDerivative · entry 2 Cano Health, Inc. · CIK 0001800682 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 6,125,998 F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.16 to $1.325. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 17:06 UTC |
Cano Health, Inc.10% owner
|
SaleClass A Common Stock | 1,125,549 | $1.39 | $1,564,513.11 |
DisclosureSEC source: 0001209191-24-002183 · doc4.xml · nonDerivative · entry 1 Cano Health, Inc. · CIK 0001800682 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 6,596,880 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.29 to $1.64. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer. Read SEC document |
| January 19, 2024 Filed Jan 19, 2024 18:09 UTC |
Cano Health, Inc.10% owner
|
SaleClass A Common Stock | 19,692 | $1.22 | $24,024.24 |
DisclosureSEC source: 0001209191-24-001958 · doc4.xml · nonDerivative · entry 3 Cano Health, Inc. · CIK 0001800682 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 7,722,429 F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.22 to $1.24. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer. Read SEC document |
| January 18, 2024 Filed Jan 19, 2024 18:09 UTC |
Cano Health, Inc.10% owner
|
SaleClass A Common Stock | 16,733 | $1.29 | $21,585.57 |
DisclosureSEC source: 0001209191-24-001958 · doc4.xml · nonDerivative · entry 2 Cano Health, Inc. · CIK 0001800682 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 7,742,121 F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.28 to $1.31. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer. Read SEC document |
| January 17, 2024 Filed Jan 19, 2024 18:09 UTC |
Cano Health, Inc.10% owner
|
SaleClass A Common Stock | 15,200 | $1.30 | $19,760.00 |
DisclosureSEC source: 0001209191-24-001958 · doc4.xml · nonDerivative · entry 1 Cano Health, Inc. · CIK 0001800682 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 7,758,854 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.29 to $1.31. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer. Read SEC document |
| January 16, 2024 Filed Jan 16, 2024 19:07 UTC |
Cano Health, Inc.10% owner
|
SaleClass A Common Stock | 5,016 | $1.31 | $6,570.96 |
DisclosureSEC source: 0001209191-24-001669 · doc4.xml · nonDerivative · entry 3 Cano Health, Inc. · CIK 0001800682 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 7,774,054 F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.30 to $1.40. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer. Read SEC document |
| January 12, 2024 Filed Jan 16, 2024 19:07 UTC |
Cano Health, Inc.10% owner
|
SaleClass A Common Stock | 29,969 | $1.51 | $45,253.19 |
DisclosureSEC source: 0001209191-24-001669 · doc4.xml · nonDerivative · entry 2 Cano Health, Inc. · CIK 0001800682 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 7,779,070 F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.48 to $1.55. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer. Read SEC document |
| January 11, 2024 Filed Jan 16, 2024 19:07 UTC |
Cano Health, Inc.10% owner
|
SaleClass A Common Stock | 24,914 | $1.53 | $38,118.42 |
DisclosureSEC source: 0001209191-24-001669 · doc4.xml · nonDerivative · entry 1 Cano Health, Inc. · CIK 0001800682 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 7,809,039 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.50 to $1.68. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer. Read SEC document |
| January 10, 2024 Filed Jan 10, 2024 17:57 UTC |
Cano Health, Inc.10% owner
|
SaleClass A Common Stock | 38,141 | $1.69 | $64,458.29 |
DisclosureSEC source: 0001209191-24-001390 · doc4.xml · nonDerivative · entry 3 Cano Health, Inc. · CIK 0001800682 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 7,833,952 F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.65 to $1.7225. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer. Read SEC document |
| January 09, 2024 Filed Jan 10, 2024 17:57 UTC |
Cano Health, Inc.10% owner
|
SaleClass A Common Stock | 36,016 | $1.73 | $62,307.68 |
DisclosureSEC source: 0001209191-24-001390 · doc4.xml · nonDerivative · entry 2 Cano Health, Inc. · CIK 0001800682 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 7,872,093 F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.70 to $1.94. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 17:57 UTC |
Cano Health, Inc.10% owner
|
SaleClass A Common Stock | 51,891 | $1.92 | $99,630.72 |
DisclosureSEC source: 0001209191-24-001390 · doc4.xml · nonDerivative · entry 1 Cano Health, Inc. · CIK 0001800682 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 7,908,109 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.90 to $2.00. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 19:50 UTC |
Cano Health, Inc.10% owner
|
SaleClass A Common Stock | 40,000 | $2.10 | $84,160.00 |
DisclosureSEC source: 0001209191-24-001081 · doc4.xml · nonDerivative · entry 1 Cano Health, Inc. · CIK 0001800682 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 7,960,000 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.15. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: Reflects securities held directly by Cano Health, LLC, an indirect subsidiary of the Issuer. Read SEC document |
| December 18, 2023 Filed Dec 21, 2023 16:05 UTC |
HAWKINS THOMAS WDirector
|
GrantClass A Common Stock | 23,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-072196 · ownership.xml · nonDerivative · entry 1 HAWKINS THOMAS W · CIK 0001015731 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,133 Read SEC document |
| December 18, 2023 Filed Dec 21, 2023 16:05 UTC |
Arrigo Michael FrederickDirector
|
GrantClass A Common Stock | 23,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-072205 · ownership.xml · nonDerivative · entry 1 Arrigo Michael Frederick · CIK 0001928569 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,588 Read SEC document |
| December 18, 2023 Filed Dec 21, 2023 21:05 UTC |
MELTZER ROGERDirector
|
GrantClass A Common Stock | 23,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-072198 · ownership.xml · nonDerivative · entry 1 MELTZER ROGER · CIK 0001259072 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,733 Read SEC document |
| December 18, 2023 Filed Dec 21, 2023 21:05 UTC |
Sternberg OphirDirector · 10% owner
|
GrantClass A Common Stock | 23,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-072199 · ownership.xml · nonDerivative · entry 1 Sternberg Ophir · CIK 0001793414 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,036 Read SEC document |
| October 26, 2023 Filed Oct 26, 2023 10:07 UTC |
Ruiz John HasanDirector · Chief Executive Officer · 10% owner
|
PurchaseMSP Recovery, Inc. | 467,290 | $1.07 | $500,000.30 |
DisclosureSEC source: 0001926798-23-000001 · primary_doc.xml · nonDerivative · entry 1 Ruiz John Hasan · CIK 0001926798 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 474,190 Read SEC document |
| September 29, 2023 Filed Oct 2, 2023 21:04 UTC |
Quesada Frank CarlosDirector · Chief Legal Officer · 10% owner
|
PurchaseMSP Recovery, Inc. | 6,868,132 | $0.22 | $1,500,000.03 |
DisclosureSEC source: 0001926804-23-000001 · primary_doc.xml · nonDerivative · entry 1 Quesada Frank Carlos · CIK 0001926804 · Director · Chief Legal Officer · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,007,041 Read SEC document |
| April 18, 2023 Filed May 1, 2023 11:16 UTC |
Rapisarda Paul Howard10% owner
|
SaleWarrant · Derivative | 250,000 | $0.01 Strike: $11.50 | $2,500.00 |
DisclosureSEC source: 0001487846-23-000011 · primary_doc.xml · derivative · entry 6 Rapisarda Paul Howard · CIK 0001487846 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,675,732 Underlying: Class A · 250,000 shares Expires 2027-05-23 Read SEC document |
| April 17, 2023 Filed May 1, 2023 11:16 UTC |
Rapisarda Paul Howard10% owner
|
SaleWarrant · Derivative | 300,000 | $0.01 Strike: $11.50 | $3,000.00 |
DisclosureSEC source: 0001487846-23-000011 · primary_doc.xml · derivative · entry 5 Rapisarda Paul Howard · CIK 0001487846 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,925,732 Underlying: Class A · 300,000 shares Expires 2027-05-23 Read SEC document |
| April 14, 2023 Filed May 1, 2023 11:16 UTC |
Rapisarda Paul Howard10% owner
|
SaleWarrant · Derivative | 18,567 | $0.01 Strike: $11.50 | $222.80 |
DisclosureSEC source: 0001487846-23-000011 · primary_doc.xml · derivative · entry 4 Rapisarda Paul Howard · CIK 0001487846 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,225,732 Underlying: Class A · 18,567 shares Expires 2027-05-23 Read SEC document |
| April 11, 2023 Filed May 1, 2023 11:16 UTC |
Rapisarda Paul Howard10% owner
|
SaleWarrant · Derivative | 50,000 | $0.02 Strike: $11.50 | $750.00 |
DisclosureSEC source: 0001487846-23-000011 · primary_doc.xml · derivative · entry 3 Rapisarda Paul Howard · CIK 0001487846 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,244,299 Underlying: Class A · 50,000 shares Expires 2027-05-23 Read SEC document |
| April 04, 2023 Filed May 1, 2023 11:16 UTC |
Rapisarda Paul Howard10% owner
|
SaleWarrant · Derivative | 225,000 | $0.02 Strike: $11.50 | $3,375.00 |
DisclosureSEC source: 0001487846-23-000011 · primary_doc.xml · derivative · entry 2 Rapisarda Paul Howard · CIK 0001487846 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,294,299 Underlying: Class A · 225,000 shares Expires 2027-05-23 Read SEC document |
| April 03, 2023 Filed May 1, 2023 11:16 UTC |
Rapisarda Paul Howard10% owner
|
SaleWarrant · Derivative | 225,000 | $0.02 Strike: $11.50 | $3,375.00 |
DisclosureSEC source: 0001487846-23-000011 · primary_doc.xml · derivative · entry 1 Rapisarda Paul Howard · CIK 0001487846 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,519,299 Underlying: Class A · 225,000 shares Expires 2027-05-23 Read SEC document |
| March 31, 2023 Filed Mar 31, 2023 17:41 UTC |
Rapisarda Paul Howard10% owner
|
SaleWarrant · Derivative | 250,000 | $0.02 Strike: $11.50 | $3,750.00 |
DisclosureSEC source: 0001487846-23-000010 · primary_doc.xml · derivative · entry 6 Rapisarda Paul Howard · CIK 0001487846 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,744,299 Underlying: Class A · 250,000 shares Expires 2027-05-23 Read SEC document |
| March 30, 2023 Filed Mar 31, 2023 17:41 UTC |
Rapisarda Paul Howard10% owner
|
SaleWarrant · Derivative | 100,000 | $0.02 Strike: $11.50 | $1,500.00 |
DisclosureSEC source: 0001487846-23-000010 · primary_doc.xml · derivative · entry 5 Rapisarda Paul Howard · CIK 0001487846 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,994,299 Underlying: Class A · 100,000 shares Expires 2027-05-23 Read SEC document |
| March 29, 2023 Filed Mar 31, 2023 17:41 UTC |
Rapisarda Paul Howard10% owner
|
SaleWarrant · Derivative | 150,000 | $0.01 Strike: $11.50 | $1,875.00 |
DisclosureSEC source: 0001487846-23-000010 · primary_doc.xml · derivative · entry 4 Rapisarda Paul Howard · CIK 0001487846 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,094,299 Underlying: Class A · 150,000 shares Expires 2027-05-23 Read SEC document |
| March 27, 2023 Filed Mar 31, 2023 17:41 UTC |
Rapisarda Paul Howard10% owner
|
SaleWarrant · Derivative | 47,800 | $0.02 Strike: $11.50 | $717.00 |
DisclosureSEC source: 0001487846-23-000010 · primary_doc.xml · derivative · entry 3 Rapisarda Paul Howard · CIK 0001487846 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,244,299 Underlying: Class A · 47,800 shares Expires 2027-05-23 Read SEC document |
| March 24, 2023 Filed Mar 31, 2023 17:41 UTC |
Rapisarda Paul Howard10% owner
|
SaleWarrant · Derivative | 225,000 | $0.02 Strike: $11.50 | $3,375.00 |
DisclosureSEC source: 0001487846-23-000010 · primary_doc.xml · derivative · entry 2 Rapisarda Paul Howard · CIK 0001487846 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,292,099 Underlying: Class A · 225,000 shares Expires 2027-05-23 Read SEC document |
| March 20, 2023 Filed Mar 31, 2023 17:41 UTC |
Rapisarda Paul Howard10% owner
|
SaleWarrant · Derivative | 8,800 | $0.02 Strike: $11.50 | $132.00 |
DisclosureSEC source: 0001487846-23-000010 · primary_doc.xml · derivative · entry 1 Rapisarda Paul Howard · CIK 0001487846 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,517,099 Underlying: Class A · 8,800 shares Expires 2027-05-23 Read SEC document |
| March 17, 2023 Filed Mar 17, 2023 15:53 UTC |
Rapisarda Paul Howard10% owner
|
SaleWarrant · Derivative | 75,000 | $0.02 Strike: $11.50 | $1,312.50 |
DisclosureSEC source: 0001487846-23-000009 · primary_doc.xml · derivative · entry 4 Rapisarda Paul Howard · CIK 0001487846 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,300,899 Underlying: Class A · 75,000 shares Expires 2027-05-23 Read SEC document |
| March 16, 2023 Filed Mar 17, 2023 15:53 UTC |
Rapisarda Paul Howard10% owner
|
SaleWarrant · Derivative | 125,000 | $0.02 Strike: $11.50 | $2,187.50 |
DisclosureSEC source: 0001487846-23-000009 · primary_doc.xml · derivative · entry 3 Rapisarda Paul Howard · CIK 0001487846 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,375,899 Underlying: Class A · 125,000 shares Expires 2027-05-23 Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 15:53 UTC |
Rapisarda Paul Howard10% owner
|
SaleWarrant · Derivative | 25,000 | $0.02 Strike: $11.50 | $500.00 |
DisclosureSEC source: 0001487846-23-000009 · primary_doc.xml · derivative · entry 2 Rapisarda Paul Howard · CIK 0001487846 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,500,899 Underlying: Class A · 25,000 shares Expires 2027-05-23 Read SEC document |
| March 10, 2023 Filed Mar 17, 2023 15:53 UTC |
Rapisarda Paul Howard10% owner
|
SaleWarrant · Derivative | 50,000 | $0.02 Strike: $11.50 | $1,000.00 |
DisclosureSEC source: 0001487846-23-000009 · primary_doc.xml · derivative · entry 1 Rapisarda Paul Howard · CIK 0001487846 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,525,899 Underlying: Class A · 50,000 shares Expires 2027-05-23 Read SEC document |
| February 15, 2023 Filed Feb 23, 2023 15:26 UTC |
Rapisarda Paul Howard10% owner
|
SaleWarrant · Derivative | 100,000 | $0.02 Strike: $11.50 | $2,000.00 |
DisclosureSEC source: 0001487846-23-000008 · primary_doc.xml · derivative · entry 2 Rapisarda Paul Howard · CIK 0001487846 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,475,899 Underlying: Class A · 100,000 shares Expires 2027-05-23 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.